ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Battelle Wins Big Toxiology Contract

March 22, 1974

Small Business Technology Transfer Program Solicitation

June 23, 1995

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Whole Brain Radiation Raises Risk Of Memory Problems

September 26, 2008

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995